{"id":"W3194137308","doi":"10.1016/j.jaad.2021.06.356","title":"26085 Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Apremilast; Medicine; Psoriasis; Placebo; Dermatology; Plaque psoriasis; Clinical trial; Internal medicine; Alternative medicine; Psoriatic arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001531154,0.0008686971,0.001549861,0.0002413596,0.0003607097,0.000810468,0.0003506863,0.001088554,0.01023637],"category_scores_gemma":[0.001024436,0.0003658348,0.001156894,0.0001976984,0.0004825318,0.0007052147,0.0002304118,0.002603413,0.00166815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003097367,"about_ca_system_score_gemma":0.0005496054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003173393,"about_ca_topic_score_gemma":0.0009876936,"domain_scores_codex":[0.9996011,0.00022628,0.0000203871,0.00004404374,0.00004216799,0.00006608597],"domain_scores_gemma":[0.9995846,0.0001255489,0.00007922157,0.00003279317,0.00003328897,0.0001445504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8734191,0.007013341,0.001884139,0.001518293,0.001473658,0.0001763295,0.0000993748,0.001041005,0.0123166,0.0007012338,0.01181114,0.08854567],"study_design_scores_gemma":[0.8297184,0.1510582,0.008268975,0.0001135256,0.0005566055,0.0002598113,0.00004059837,0.0007523822,0.001229812,0.0005757069,0.007391317,0.00003470037],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9448815,0.02054437,0.001551786,0.002972214,0.0009502519,0.003929524,0.004768916,0.0004807123,0.01992068],"genre_scores_gemma":[0.9749109,0.004465968,0.002032232,0.002699445,0.0005965352,0.001916569,0.003125628,0.00005009788,0.01020254],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01023637,"threshold_uncertainty_score":0.034244,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01308272054913317,"score_gpt":0.2758625563854852,"score_spread":0.2627798358363521,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}